Drugs / GAVILIMOMAB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00035880 | Oct 1999 → Jun 2003 | acute graft versus host disease | Abgenix | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GAVILIMOMAB | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109193 ↗ |
| Known as | ABX-CBL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00035880 ↗ |
| Modality | Monoclonal antibody | “ABX-CBL (Monoclonal Antibody)” NCT00035880 ↗ |
| Target | BSG | “Basigin other” CHEMBL2109193 ↗ |